Simon Baker's Stock Ratings

Redburn Atlantic Analyst

Simon Baker is an analyst at Redburn Atlantic. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025

Overall Average Return

-9.22%

Smart Score

26%

Overall Average Return Percentile

22nd

Number of Ratings

9
Buy NowGet Alert
11/15/2024AUTLBuy Now
Autolus Therapeutics
$1.65687.88%
Simon Baker25%
→ $13UpgradeNeutral → BuyGet Alert
05/17/2023BNTXBuy Now
BioNTech
$97.2274.86%
Simon Baker25%
$165 → $170UpgradeNeutral → BuyGet Alert
02/01/2022BNTXBuy Now
BioNTech
$97.22—
Simon Baker25%
—UpgradeSell → NeutralGet Alert
10/14/2021QGENBuy Now
Qiagen
$39.60—
Simon Baker25%
—Initiates → BuyGet Alert
10/14/2021ABTBuy Now
Abbott Laboratories
$125.60—
Simon Baker25%
—Initiates → NeutralGet Alert
10/14/2021HOLXBuy Now
Hologic
$61.23—
Simon Baker25%
—Initiates → NeutralGet Alert
06/16/2021BNTXBuy Now
BioNTech
$97.22—
Simon Baker25%
—DowngradeNeutral → SellGet Alert
04/08/2020FOXABuy Now
Fox
$54.81-56.21%
Simon Baker25%
$29 → $24UpgradeSell → HoldGet Alert
01/22/2015FOXABuy Now
Fox
$54.81-34.32%
Simon Baker25%
→ $36Initiates—Get Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free